CAH
Cardinal Health, Inc. · Healthcare · Medical - Distribution
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | +5 | 163.00M | $38.69B | +9 | −3 |
| Q1 2026 | 169 | -3 | 156.75M | $33.07B | — | −4 |
| Q4 2025 | 171 | +1 | 178.08M | $36.60B | +2 | — |
| Q3 2025 | 22 | 0 | 113.76M | $17.85B | +1 | −2 |
| Q2 2025 | 20 | 0 | 103.35M | $17.36B | +1 | −1 |
| Q1 2025 | 17 | -1 | 36.99M | $5.09B | — | −1 |
| Q4 2024 | 18 | 0 | 42.27M | $5.00B | +1 | −1 |
| Q3 2024 | 17 | 0 | 26.27M | $2.90B | — | — |
| Q2 2024 | 17 | — | 25.18M | $2.47B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 5.71M | — | $559.68M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 5.71M | — | $559.68M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Arrowstreet Capital ✦ | 3.72M | — | $365.86M | 0.3% | n/c | 1 | SEC ↗ |
| 4 | AQR Capital Management ✦ | 3.46M | — | $340.47M | 0.5% | n/c | 1 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 3.46M | — | $340.47M | 0.5% | n/c | 1 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 3.46M | — | $340.47M | 0.5% | n/c | 1 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 2.12M | — | $208.48M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 2.12M | — | $208.48M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 2.10M | — | $206.80M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Elliott Investment Management ✦ | 2.00M | — | $196.64M | 2.0% | n/c | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 1.68M | — | $165.52M | 0.3% | n/c | 1 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 919.85K | — | $90.44M | 0.3% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 807.49K | — | $79.39M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 807.49K | — | $79.39M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Millennium Management ✦ | 799.14K | — | $78.57M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 733.55K | — | $72.12M | 0.2% | n/c | 1 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 470.82K | — | $46.29M | 0.2% | n/c | 1 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 313.93K | — | $30.87M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 313.93K | — | $30.87M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 233.60K | — | $22.97M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 68.46K | — | $6.73M | 0.1% | n/c | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 20.13K | — | $1.98M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Wellington Management ✦ | 18.67K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Wellington Management ✦ | 18.67K | — | $1.84M | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,414 holders, 197.98M shares, $39.62B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 6.73K sh · $1.59M
Officer · 16.19K sh · $3.84M
Officer · 6.24K sh · $1.49M
Officer · 6.21K sh · $1.45M
Officer · 3.46K sh · $809,941
Officer · 5.70K sh · $1.34M
Officer · 100 sh · $23,740
Officer · 2.20K sh · $522,733
Officer · 3.90K sh · $915,096
Officer · 10.25K sh · $2.41M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology